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Abstract: Objective: The present study was carried out to evaluate cerebral perfusion in different types of cerebral 
palsy (CP) patients. For those patients who underwent hyperbaric oxygen therapy, brain perfusion before and after 
the therapy was compared. Methods: A total of 11 CP patients were enrolled in this study, of which 4 patients under-
went oxygen therapy. Before oxygen therapy and at the end of 40 sessions of oxygen treatment, 99mTc-ECD brain 
perfusion single photon emission computed tomography (SPECT) was performed , and the results were compared. 
Results: A total of 11 CP patients, 7 females and 4 males with an age range of 5-27 years participated in the study. 
In brain SPECT studies, all the patients showed perfusion impairments. The region most significantly involved was 
the frontal lobe (54.54%), followed by the temporal lobe (27.27%), the occipital lobe (18.18%), the visual cortex 
(18.18%), the basal ganglia (9.09%), the parietal lobe (9.09%), and the cerebellum (9.09%). Frontal-lobe hypoperfu-
sion was seen in all types of cerebral palsy. Two out of 4 patients (2 males and 2 females) who underwent oxygen 
therapy revealed certain degree of brain perfusion improvement. Conclusion: This study demonstrated decreased 
cerebral perfusion in different types of CP patients. The study also showed that hyperbaric oxygen therapy improved 
cerebral perfusion in a few CP patients. However, it could keep the physiological discussion open and strenghten a 
link with other areas of neurology in which this approach may have some value.
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Introduction
Cerebral palsy (CP) is a nonprogressive disease 
that presents as a disorder of motion and pos-
ture following brain injury during a period of 
development. Hypoxic-ischemic encephalopa-
thy (HIE) is one of the major causes of the dis-
ability entity [1].
There is no specific diagnostic test for the 
diagnosis of CP except careful physical ex- 
aminations [2]. Anatomic imaging may be a 
useful modality in the diagnosis and dete- 
ction of brain lesions in CP patients; 82% of 
patients who were born prematurely and 55% 
of patients born at term have abnormal struc-
tural findings on magnetic resonance imaging 
(MRI) [1].
On the other hand, functional imaging is able to 
detect brain lesions in CP cases in which lesions 
were not detectable using conventional MRI. A 
PET study showed focal areas of cortical hypo-
metabolism in the absence of apparent struc-
tural abnormalities [3]. Single photon emission 
computed tomography (SPECT) is a useful 
method to detect cerebral lesions that are not 
detectable in patients with CP by MRI [4].
The present study was designed to evaluate the 
brain perfusion SPECT of patients with CP and 
to compare the results with their clinical fea-
tures. There is no study to date based on the 
evaluation of SPECT of patients with CP who 
received oxygen therapy; therefore, this study 
included an evaluation of the changes of 
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SPECTs before and after oxygen therapy in 
patients with CP.
Materials and methods
Participants and study design 
The study population consists of 11 patients (4 
males and 7 females with an age range of 5-27 
years) with CP following perinatal asphyxia that 
was diagnosed by physical examinations and 
laboratory tests, including electroencephalog-
raphy and electromyography. The patients were 
referred from the neurology department to our 
center for the assessment of brain perfusion 
between May 2010 and December 2012. 
Patients with cerebral palsy of postneonatal 
onset were excluded, as were those with other 
causes of encephalopathy. Children who had 
experienced one recent episode (within 1 
month) of acute otitis or those with chronic oti-
tis (three episodes or more within the previous 
year) were excluded, as were those with any 
condition that put them at risk for complica-
tions of hyperbaric oxygen (e.g., asthma, con-
vulsions). Children with behavioral problems, or 
those recently treated with botulinum toxin or 
orthopedic surgery (within the past 6 months) 
or dorsal rhizotomy within the past 2 years, 
were also excluded. Previous exposure to 
hyperbaric oxygen was also an exclusion crite-
rion. Antispasticity medication, drugs affecting 
concentration, and physiotherapy were stopped 
6 weeks before the trial.
Among the 11 patients, there were 4 who 
met these criteria and who were undergoing 
oxygen therapy. Hyperbaric oxygen treatment 
consisted of 100% oxygen at a pressure of 1.75 
atm absolute (ATA) for 60 minutes. A complete 
intervention comprised 40 sessions: once per 
day, 5 days per week, for 8 weeks. At the end of 
40 sessions of oxygen therapy, brain SPECT 
was performed again; the results were then 
evaluated and compared with previous SPECT 
results.
This study complies with the Declaration of 
Helsinki and was approved by our institutional 
ethics committee; all patients’ parents gave 
written informed consent.
Imaging protocols
All patients underwent 99mTc-ECD brain SPECT 
scan and a dose of 99mTc-ECD based on the 
patient’s weight. The administered activity of 
99mTc-ECD was 0.2-0.3 mCi/Kg. A commercial 
ECD kit (AEOI, Tehran, Iran) was used, and the 
labeling and quality control procedures were 
performed according to the manufacturer’s 
instructions. The radiochemical purity was cal-
culated by comparing the peak for the 99mTc-
ECD complex to the sum of all other peaks on 
the plate. The radiochemical purities of 99mTc-
ECD were higher than 97%.
All subjects had an intravenous (IV) line estab-
lished while they were lying down, with their 
eyes closed and ears unplugged, in a quiet, 
darkened room with low ambient sound and 
light. After approximately 30 minutes, each 
subject received an 800-MBq IV injection of 
tracer while they were still lying down in the 
same quiet, darkened room. One hour after an 
IV injection of 800 MBq 99mTc-ECD in a room 
with a low level of ambient light and minimal 
background noise, the SPECT procedure was 
performed. Scans were performed using a 
dual-head gamma camera (Siemens, Germany) 
that was equipped with a pair of low-energy and 
high-resolution collimators. The full width at 
half maximum (FWHM) of this system, as mea-
sured in-house, was 12-mm for Tc-99m. 
Standard head positioning was based on a uni-
form alignment of the external auditory meatus 
using automated table positioning and camera-
to-head-detector ratio values. The total acquisi-
tion time was 35 minutes for each study. 
Images were acquired in a 64 _ 64 _ 64 three-
dimensional pixel matrix at 64 steps, 30 sec-
onds per step. Before reconstruction of the 
images, attenuation correction of the images 
was carried out by the Chang method (attenua-
tion coefficient 0.12 cm_1). The data were then 
processed by back projection and filtered with 
a Butterworth filter, using a Nyquist frequency 
cut-off of 0.5 and order of 5. Images were 
reconstructed and displayed in all three orthog-
onal planes.
Image interpretation
Scintigraphic results were analyzed by two 
experienced nuclear medicine physicians who 
were not aware of the patients’ medical histo-
ries; differences of judgment were resolved by 
consensus. The frontal, parietal, temporal, 
occipital cortex, basal ganglia, brainstem, and 
cerebellum were analyzed systematically. 
Normal brain SPECT findings included homoge-
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athetoid type. Extratemporal cortices, particu-
larly frontal, commonly showed hypoperfusion 
in the spastic quadriparetic type. In the spastic 
diplegia type, the temporal, as well as the extra-
temporal cortices showed abnormalities.
Based upon the pattern of motor impairment, 
CP is classified into several clinical subtypes: 
spastic quadriparesis, spastic diplegia, spastic 
or infantile hemiplegia, and an extrapyramidal 
variant with choreoathetoid or dystonic fea-
tures. Generally, patients are placed in a par-
ticular subtype based upon predominant clini-
cal manifestations during examination, 
although overlapping features in patients are 
common [5].
The pattern of hypoxic brain damage following 
perinatal asphyxia is different, depending on 
the gestational age of the fetus at the time the 
injury occurred [6]. In premature infants, the 
main pattern of damage is periventricular leu-
komalacia (PVL), which is characterized by a 
loss of periventricular white matter and associ-
ated with ventriculomegaly. In addition, PVL 
may be distributed to affect areas of white mat-
ter other than periventricular [6]. At the neona-
tal stage, asphyxia involves neocortical and 
subcortical white matter and also the basal 
ganglia, including the thalamus, the putamen, 
the globus pallidus, and the caudate nucleus. 
The clinical picture of CP is related to the distri-
bution of cerebral lesions. Spastic diplegia is 
associated with PVL. In cases where lesions 
extend to the subcortical area, patterns of tet-
raplegia are seen that are frequently associat-
neous rCBF in the mentioned regions without 
focal hypoperfusion or visible asymmetry. 
Abnormal brain SPECT findings were defined as 
heterogeneous rCBF with focal hypoperfusion 
or visible asymmetry in at least two consecu-
tive slices in two sections.
Results
The patients were grouped into one of the 
following major clinical subtypes based on the 
predominant features of their motor impair-
ments: spastic diplagia (n = 2), spastic quadrip-
lagia (n = 3), spastic paraplegia (n = 4), and 
choreathetoid (n = 2) (Table 1).
On the SPECT study, all patients showed perfu-
sion impairments. The region most significantly 
involved was the frontal lobe (54.54%), followed 
by the temporal lobe (27.27%), the occipital 
lobe (18.18%), the visual cortex (18.18%), the 
basal ganglia (9.09%), the parietal lobe (9.09%), 
and the cerebellum (9.09%) (Table 1).
Frontal lobe hypoperfusion was seen in all 
types of cerebral palsy. Cerebral cortex hypo-
perfusion was seen in all types of cerebral 
palsy except diplagia. Hypoperfusion of the 
basal ganglia and of the cerebellum was seen 
in just 25% of the patients with spastic paraple-
gia. Parietal lobe hypoperfusion was observed 
in just 33% of the patients with spastic 
quadriplegia.
Among the 11 patients, 4 (2 males and 2 
females) underwent oxygen therapy, after 
which two of them re- 
vealed some degree of 
brain perfusion improve-
ment (Table 2) (Figures 1 
and 2).
Discussion
Our study showed abnor-
mal perfusion scans in all 
patients with CP. Although 
specific perfusion defects 
were not detected for 
every type of CP, some 
areas involved were more 
common than others in 
one type. The basal gan-
glia was involved in all 
patients with the chore-
Table 1. Demographic data and results of 99mTc-ECD brain SPECT in 
every cerebral palsy patient
Case Sex Age Cp type
Visual 
cortex
Fron- 
tal
Occi- 
pital
Tem- 
poral
Parie- 
tal
Cerebe- 
llum
Cor- 
tex
Sub- 
cortex
1 M 11 SP + + +
2 M 6.5 SP +
3 F 12 C + +
4 F 22 C +
5 F 27 SQ +
6 F 26 SD + + +
7 F 5 SQ + + +
8 F 10 SP +
9 M 7 SQ + + +
10 F 23 SD + +
11 M 24 SP + +
SP, spastic paraplegic; C, choreathetoid; SQ, spastic quadriplegic; SD, spastic diplegic.
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Table 2. Brain perfusion SPECT data of cerebral palsy patients who underwent oxygen therapy
Case Sex Age CP type SPECT before SPECT after Change
1 F 12 C Mild diffuse cortical and subcortical hypoperfusion normal Yes
2 F 27 SQ Moderate hypoperfusion confined to left visual cortex Moderate hypoperfusion confined to left visual cortex  No
3 M 7 SQ Moderate hypoperfusion through the frontal and parietals lobes and also 
caudate nucleus (R > L)
Mild hypoperfusion through the frontal and parietals lobes and also caudate 
nucleus (R > L)
Yes
4 M 24 SP Moderate hypoperfusion of the right visual cortex with extension to the occipital 
zone and moderate bilateral hypoperfusion of the subcortical structures
Moderate hypoperfusion of the right visual cortex with extension to the occipital 
zone and moderate bilateral hypoperfusion of the subcortical structures
No
Brain perfusion SPECT in CP
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Figure 1. Pre-treatment (upper rows) and post-treatment (lower rows) SPECT images of a 12-year-old CP patient. 
There is a mild diffuse cortical and subcortical  hypoperfusion on pretreatment 99mTc-ECD brain perfusion SPECT, 
which is normalized after O2 therapy. The left columns indicate transvers 99mTc-ECD SPECT images; the middle 
columns indicate sagittal 99mTc-ECD SPECT images; and the right columns indicate coronal 99mTc-ECD SPECT 
images. 
Figure 2. Pre-treatment (upper rows) and post-treatment (lower rows) SPECT images of a 7-year-old CP patient. 
There is a moderate hypoperfusion through the frontal and  parietals lobes and also caudate nucleus (R > L) on 
pretreatment 99mTc-ECD brain perfusion SPECT, which is partially reperfused after O2 therapy. The left columns 
indicate transvers 99mTc-ECD SPECT images; the middle columns indicate sagittal 99mTc-ECD SPECT images; and 
the right columns indicate coronal 99mTc-ECD SPECT images. 
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ed with mental retardation and epilepsy. 
Involvement of the basal ganglia results in 
additional extrapyramidal symptoms [6].
Decreased periventricular white matter and 
increased signals in the region, with close 
approximation of the posterior temporal and 
occipital cortices to the ventricular wall, are 
characteristic MR findings of PVL in HIE [1]. 
Other MRI findings include abnormalities in the 
temporal and extratemporal cortices, thalamic 
abnormality, and basal ganglia and cerebellar 
atrophy [1].
Lee et al. investigated cerebral perfusion in 51 
patients with different types of CP and reported 
that thalamic hypoperfusion was present in 
nearly all cases, and in also every type. Other 
perfusion abnormalities revealed in the study 
were detected the temporal lobe, cerebellum, 
basal ganglia, and extratemporal and temporal 
cortices, respectively [1].
With respect to CP classification, spastic diple-
gia was associated with the thalamus, tempo-
ral cortices, cerebellum, basal ganglia, and 
extratemporal cortices hypoperfusion. Spastic 
quadriplegia demonstrated a similar pattern, 
although the extratemporal site involved more 
than diplegia, and the incidence of temporal 
cortices hypoperfusion was reported to be 
lower. The basal ganglia and thalamus were 
commonly involved in the choreathethoid type 
[1].
Similarly, a study by Kerrigan et al. showed that 
thalamic hypoperfusion and hypometabolism 
are important manifestations in CP. The study 
reported thalamic hypometabolism in 2 of 4 
patients with spastic diplegia, 6 of 7 with infan-
tile hemiparesis, and 5 of 5 with choreoathe-
toid types [3].
Kerrigan et al.’s PET study showed metabolism 
abnormalities in CP patients [3] and revealed 
severe and diffuse abnormal cerebral glucose 
utilization concomitant with small, scattered 
remnants of cortical and subcortical activity in 
patients with spastic quadriplegia and bilateral 
multicystic encephalomalacia in structural 
imaging. In the spastic diplegia group, common 
abnormalities included unilateral parieto-occip-
ital hypometabolism. The study showed 
decreased glucose utilization in the lenticular 
nucleus and thalamus in choreoathetoid types 
[3].
Some degree of discrepancy in the results of 
this study may originate from the study method 
(the type of functional imaging study and case 
selection), as well as the cause of the CP (all 
our patients had a history of perinatal 
asphyxia).
Cerebral hypoperfusion in CP originated from 
several mechanisms. Neuronal loss seemed to 
be a main cause of decreased cerebral perfu-
sion. Even without the detection of obvious 
brain lesions in structural imaging, it is possible 
for significant hypoperfusion to occur. Brain 
SPECT is considered to be a functional imaging 
that has the capability to reveal the area of 
hypoperfusion following neuronal loss, where-
as MRI is able to detect irreversible damage to 
tissue with cerebral blood flow lower than 10 
ml/100 g of tissue/1 min [1]. Another reason 
for the inconsistency is the effect of thalamic 
lesions on the perfusion of other regions of the 
brain, which is defined as classical thalamocor-
tical diaschisis [7]. Thalamic damage is a com-
mon finding in hypoxic brain damage, as dem-
onstrated by Eken et al. [8]. The typical 
thalamocortical diaschisis is decreased metab-
olism or perfusion of the corresponding cere-
bral cortex following unilateral thalamic lesion, 
and retrograde thalamocortical diaschisis is 
decreased metabolism or blood flow in the ipsi-
lateral thalamus, associated with the infarcted 
cerebral cortex [7]. Therefore, pathologies that 
commonly occur in CP, such as white matter 
lesions or PVL, could interrupt the cortico-tha-
lamic connection, resulting in thalamic hypo-
perfusion by diachisis .
Hyperbaric oxygen therapy has been used to 
treat children with CP. The rationale for this 
treatment is improved oxygenation of the 
brain’s damaged tissue [9]. At the cellular level, 
hyperbaric oxygen therapy seems to ameliorate 
neuronal and glia cells mitochondrial function 
and, eventually, cellular metabolism; it also 
appears to reduce oxidative stress, augment 
neurotrophins and nitric oxide concentration, 
and up-regulate axon guidance agents. The 
treatment may also induce neurogenesis and 
reduce apoptosis [10]. Another possible mech-
anism is hyperoxia’s action as a neuronal stim-
ulant [11]. Hyperoxia decreased membrane 
conductance and effect ion channels closure, 
presumably decreasing outward (K) and/or 
inward (Cl) currents, eventually causing depo-
larization and stimulate to fire rate [11]. All the 
mechanisms can promote neuronal activity.
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In a randomized, controlled trial, Collet et al. [9] 
treated children suffering from CP with 40 ses-
sions of either oxygen or air. Although signifi-
cant improvement was seen in both groups 
with respect to motor parameters, differences 
between the groups were not significant.
Lacey et al. reported that hyperbaric oxygen 
therapy is not an effective treatment in young 
children with CP who did not have neonatal 
hypoxic-ischemic encephalopathy [12].
It should be pointed out that the current study 
has some drawbacks. One of the most impor-
tant limitations is the relatively small sample 
size; however, it was quite homogenous in 
terms of the disease severity of patients. We 
should have used semiquantitative analysis 
software as a supplementary method to pres-
ent the perfusion data. Furthermore, some 
brain perfusion studies showed improvement 
following O2 treatment without a substantial 
effect on clinical subjective and objective eval-
uation in the short-term follow up. Extended 
monitoring during a more prolonged time 
course should be considered in future studies.
Conclusion
This study demonstrated decreased cerebral 
perfusion in different types of CP patients. The 
study also revealed that hyperbaric oxygen 
therapy improved cerebral perfusion in a few 
CP patients. However, further well-designed 
studies are needed to assess these results.
Disclosure of conflict of interest
None.
Address correspondence to: Majid Assadi, The 
Persian Gulf Nuclear Medicine Research Center, 
Bushehr University of Medical Sciences, Bushehr 
3631, Iran. Tel: 0098-771-2580169; Fax: 0098-771- 
2541828; E-mail: assadipoya@yahoo.com; asadi@
bpums.ac.ir
References
[1] Lee JD, Kim DI, Ryu YH, Whang GJ, Park CI, 
Kim DG. Technetium-99m-ECD brain SPECT in 
cerebral palsy: comparison with MRI. J Nucl 
Med 1998; 39: 619-23.
[2] Truit CL, Barkovich AJ, Koch TK, Ferriero DM. 
Cerebral palsy; MR findings in 40 patinets. 
AJNR 1992; 13: 67-78.
[3] Kerrigan JF, Chugani HT, Phelp ME. Regional 
cerebral glucose metabolism in clinical sub-
types of cerebral palsy. Pediatr Neurol 1991; 
15-25.
[4] Yim SY, Lee IY, Park CH, Kim OH. A quantitative 
analysis of brain SPECT for prognostication of 
gross motor development in children with cere-
bral palsy. Clin Nucl Med 2000; 25: 268-72.
[5] Vining EPG, Accardo PJ, Rubenstein JE, Farrel 
SE, Roisen NJ. Cerebral palsy: A pediatric de-
velopmentalist’s overview. Am J Dis Child 
1976; 130: 643-9.
[6] Rademakers RP, van der Knaap MS, Verbeeten 
B Jr, Barth PG, Valk J. Central cortico-subcorti-
cal involvement: a distinct pattern of brain 
damage caused by perinatal and postnatal as-
phyxia in term infants. J Comput Assist Tomogr 
1995; 19: 256-63.
[7] Baron JC, Levasseur M, Mazoyer B, Legault-
Demare F, Mauguière F, Pappata S, Jedynak P, 
Derome P, Cambier J, Tran-Dinh S, et al. Thala-
mocortical diaschisis: positron emission to-
mography in human. J Neurol Neurosurg Psy-
chiatry 1992; 55: 935-942.
[8] Eken P. Jansen GH, Groenendaal F. Rademak-
er KJ. de Vries LS. Intracranial lesions in the 
fullterm infant with hypoxic ischaemic enceph-
alopathy: ultrasound and autopsy correlation. 
Neuropedialrics 1994: 25: 301-307.
[9] Collet JP, Vanasse M, Marois P, Amar M, Gold-
berg J, Lambert J, Lassonde M, Hardy P, Fortin 
J, Tremblay SD, Montgomery D, Lacroix J, Rob-
inson A, Majnemer A. Hyperbaric oxygen for 
children with cerebral palsy: a randomised 
multicentre trial. HBO-CP Research Group. 
Lancet 2001; 357: 582-6.
[10] Efrati S, Fishlev G, Bechor Y, Volkov O, Bergan 
J, Kliakhandler K, Kamiager I, Gal N, Friedman 
M, Ben-Jacob E, Golan H. Hyperbaric oxygen 
induces late neuroplasticity in post stroke pa-
tients--randomized, prospective trial. PLoS 
One 2013; 8: e53716.
[11] D’Agostino DP, Colomb DG Jr, Dean JB. Effects 
of hyperbaric gases on membrane nanostruc-
ture and function in neurons. J ApplPhysiol 
(1985) 2009; 106: 996-1003.
[12] Lacey DJ, Stolfi A, Pilati LE. Effects of hy- 
perbaric oxygen on motor function in children 
with cerebral palsy. Ann Neurol 2012; 72: 695-
703.
